Fisher Jr Chester L MD Newport News, VA - 23606

Fisher Jr Chester L MD is categorized under Medical Research in Newport News, VA and active since 2001.

Fisher Jr Chester L MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Chester Fisher Jr at the company’s single location by writing to 11747 Jefferson Avenue # 1b, Newport News, Virginia VA 23606 or by phoning (757) 591-8100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Fisher Jr Chester L MD
Contact Person: Chester Fisher Jr
Address: 11747 Jefferson Avenue # 1b, Newport News, Virginia 23606
Phone Number: (757) 591-8100
Website Address: advancedclinicalresearch.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 6211110
Share This Business:

Fisher Jr Chester L MD was started in 2001 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Chester Fisher Jr for inquiries that concern Fisher Jr Chester L MD by calling the company number (757) 591-8100, as your correspondence is most welcome. Additionally, the physical location of the single location of Fisher Jr Chester L MD can be found at the coordinates 37.08301,-76.48063 as well as the street address 11747 Jefferson Avenue # 1b in Newport News, Virginia 23606.

For its online presence, you may visit Fisher Jr Chester L MD’s website at advancedclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.